These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2463265)

  • 1. Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine.
    Matsubara T; Saura R; Hirohata K; Ziff M
    J Clin Invest; 1989 Jan; 83(1):158-67. PubMed ID: 2463265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper chelation by D-penicillamine generates reactive oxygen species that are cytotoxic to human leukemia and breast cancer cells.
    Gupte A; Mumper RJ
    Free Radic Biol Med; 2007 Nov; 43(9):1271-8. PubMed ID: 17893040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bucillamine inhibits T cell adhesion to human endothelial cells.
    Eguchi K; Kawakami A; Ida H; Nakashima M; Yamashita I; Sakai M; Shimada H; Terada K; Fukuda T; Ishimaru T
    J Rheumatol; 1992 Jul; 19(7):1045-50. PubMed ID: 1512757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppression by D-penicillamine in vitro. Inhibition of human T lymphocyte proliferation by copper- or ceruloplasmin-dependent generation of hydrogen peroxide and protection by monocytes.
    Lipsky PE
    J Clin Invest; 1984 Jan; 73(1):53-65. PubMed ID: 6606652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of D-penicillamine on mitogen-induced human lymphocyte proliferation: synergistic inhibition by D-penicillamine and copper salts.
    Lipsky PE; Ziff M
    J Immunol; 1978 Mar; 120(3):1006-13. PubMed ID: 632576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human endothelial cell proliferation by gold compounds.
    Matsubara T; Ziff M
    J Clin Invest; 1987 May; 79(5):1440-6. PubMed ID: 3106416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human helper T cell function in vitro by D-penicillamine and CuSO4.
    Lipsky PE; Ziff M
    J Clin Invest; 1980 May; 65(5):1069-76. PubMed ID: 6965944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of human fibroblast proliferation by D-penicillamine and copper sulfate in vitro.
    Matsubara T; Hirohata K
    Arthritis Rheum; 1988 Aug; 31(8):964-72. PubMed ID: 3261590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An investigation into copper catalyzed D-penicillamine oxidation and subsequent hydrogen peroxide generation.
    Gupte A; Mumper RJ
    J Inorg Biochem; 2007 Apr; 101(4):594-602. PubMed ID: 17275091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suggested mode of action of D-penicillamine as an immunosuppressive agent in rheumatoid arthritis.
    Lipsky PE
    Z Rheumatol; 1988; 47 Suppl 1():6-8. PubMed ID: 2975107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D-Penicillamine: analysis of the mechanism of copper-catalyzed hydrogen peroxide generation.
    Starkebaum G; Root RK
    J Immunol; 1985 May; 134(5):3371-8. PubMed ID: 2984288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo interactions of D-penicillamine with tumors.
    Samoszuk M; Nguyen V
    Anticancer Res; 1996; 16(3A):1219-23. PubMed ID: 8702240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a monoclonal antibody specific for activated endothelial cells to quantitate angiogenesis in vivo in zebrafish after drug treatment.
    Seng WL; Eng K; Lee J; McGrath P
    Angiogenesis; 2004; 7(3):243-53. PubMed ID: 15609079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced intracellular delivery of the reactive oxygen species (ROS)-generating copper chelator D-penicillamine via a novel gelatin--D-penicillamine conjugate.
    Gupte A; Wadhwa S; Mumper RJ
    Bioconjug Chem; 2008 Jul; 19(7):1382-8. PubMed ID: 18570451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the effects of the antirheumatic drugs, bucillamine and D-penicillamine, on mitogen-induced proliferation of mouse spleen cells.
    Mita S; Matsunaga K
    Agents Actions; 1990 Jun; 30(3-4):363-8. PubMed ID: 2386109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low-dose methotrexate.
    Hirata S; Matsubara T; Saura R; Tateishi H; Hirohata K
    Arthritis Rheum; 1989 Sep; 32(9):1065-73. PubMed ID: 2476134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mechanism of action of gold sodium thiomalate in diseases characterized by a proliferative synovitis: reversible changes in collagen production in cultured human synovial cells.
    Goldberg RL; Parrott DP; Kaplan SR; Fuller GC
    J Pharmacol Exp Ther; 1981 Aug; 218(2):395-403. PubMed ID: 6788936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo inhibition of activation induced T cell apoptosis by bucillamine.
    Okazaki H; Sato H; Kamimura T; Hirata D; Iwamoto M; Yoshio T; Mimori A; Masuyama JI; Kano S; Minota S
    J Rheumatol; 2000 Jun; 27(6):1358-64. PubMed ID: 10852254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mechanism of cisplatin action: antineoplastic effect through inhibition of neovascularization.
    Yoshikawa A; Saura R; Matsubara T; Mizuno K
    Kobe J Med Sci; 1997 Aug; 43(3-4):109-20. PubMed ID: 9489296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of gold and other drugs on mononuclear cell responses: a comparison.
    Harth M; Stiller CR
    J Rheumatol Suppl; 1979; 5():112-6. PubMed ID: 158654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.